• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Top PBMs increase number of formulary exclusions in 2021

News
Article

CVS Caremark, Express Scripts and OptumRx have increased the number of medications that are excluded from their national formularies.

The number of formulary exclusions from the nation’s three largest pharmacy benefits managers — Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—increased significantly in 2021, according to a new analysis.

Many exclusions are brand name treatments with generic equivalents but the PBMs are also leaving off more specialty meds, according to the Philadelphia-based Adam J. Fein, the drug pricing expert.

Related: Express Scripts reveals Digital Health Formulary coverage

“The practice of formulary exclusion began in 2014. Since then, the number of products excluded from the national preferred formularies of the three largest PBMs has grown dramatically,” wrote Fein, Ph.D., whose Drug Channels website is widely read in the industry. “The growth in excluded products shows how competitive many specialty therapy categories have become — and the undisclosed but presumably significant rebates generated by these products.”

CVS Caremark removed 57 drugs and added 6 drugs back in its 2021 standard formulary, according to Fein. Express Scripts expanded it exclusion list by 70 medications. OptumRx excluded 27 more medication in its 2021 standard formulary; by Fein’s tally, that OptumRx’s total exclusion now has 476 products on it.

Express Scripts excluded some major medications in its 2021 standard formulary, including the psoriasis drug secukinumab (Cosentyx, Novartis), the cancer medication Calquence (AstraZeneca), and the PCSK9 inhibitor Praluent (Regeneron, Sanofi).

Related: Express Scripts reveals medicare savings plans for 2020

Among the notable exclusions in CVS Caremark’s 2021 standard formulary are: the antidepression blockbuster paroxetine hydrochloride (Paxil, GlaxoSmithKline), pegfilgrastim (Neulasta, Amgen), and the otic anti-inflammatories/anti-infectives ciproflaxin hydrochloride (Cipro HC, Bayer) and (Ciprodex, Novartis).

OptumRx/ United Health excluded the blockbuster insulin Lantus (Sanofi) and anti-infection drug Neupogen (Amgen) in favor of the drugs’ biosimilars. The PBM also excluded leukemia treatment Gleevec (Novartis).

The PBMs differ in how they handle formulary exclusions and additions, Drug Channels noted. Express Scripts and OptumRx both excluded Cosentyx, but CVS Caremark did not. CVS Caremark excluded etanercept (Enbrel, Wyeth) for psoriasis only, but Express Scripts and OptumRx did not.

Read more: Formulary changes cause problems for asthmatic kids

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.